A detailed history of Pfs Investments Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, Pfs Investments Inc. holds 4,470 shares of HAE stock, worth $337,216. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,470
Previous 3,996 11.86%
Holding current value
$337,216
Previous $329,000 15.81%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$80.84 - $89.45 $38,318 - $42,399
474 Added 11.86%
4,470 $381,000
Q1 2023

May 15, 2023

BUY
$72.75 - $90.6 $290,709 - $362,037
3,996 New
3,996 $329,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.87B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Pfs Investments Inc. Portfolio

Follow Pfs Investments Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfs Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pfs Investments Inc. with notifications on news.